Axsome Therapeutics Inc (AXSM)
99.56
-0.92
(-0.92%)
USD |
NASDAQ |
Dec 04, 16:00
99.40
-0.16
(-0.17%)
After-Hours: 20:00
Axsome Therapeutics Revenue (Quarterly): 104.76M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 104.76M |
| June 30, 2024 | 87.17M |
| March 31, 2024 | 75.00M |
| December 31, 2023 | 71.53M |
| September 30, 2023 | 57.79M |
| Date | Value |
|---|---|
| June 30, 2023 | 46.70M |
| March 31, 2023 | 94.58M |
| December 31, 2022 | 24.37M |
| September 30, 2022 | 16.85M |
| June 30, 2022 | 8.82M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
8.82M
Minimum
Jun 2022
104.76M
Maximum
Sep 2024
58.76M
Average
64.66M
Median
Revenue (Quarterly) Benchmarks
| Repligen Corp | 154.87M |
| Pfizer Inc | 17.70B |
| NovaBay Pharmaceuticals Inc | 2.441M |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -64.60M |
| Total Expenses (Quarterly) | 151.00M |
| EPS Diluted (Quarterly) | -1.34 |
| Enterprise Value | 4.723B |
| Gross Profit Margin (Quarterly) | 91.95% |
| Profit Margin (Quarterly) | -61.67% |
| Earnings Yield | -6.56% |
| Normalized Earnings Yield | -5.287 |